A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
The presence of P+PBac{XP5.WH5}BSC857 was verified using the PCR methods and primers described in FBrf0175003.
The breakpoints of Df(1)BSC857 predicted from the Release 5 genomic coordinates of the insertion sites of the progenitor transposable elements P{XP}yld10478 and PBac{WH}Flo-2f04495 are X:14087266 ;14819627 and the cytological breakpoints predicted from these coordinates are 12E3;13A1.